BP
LH icon

Ballentine Partners’s Labcorp LH Stock Holding History

Ballentine Partners’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$325K Sell
1,160
-29
-2% -$7.62K ﹤0.01% 752
2026
Q1 		$317K Buy
1,189
+39
+3% +$10.6K ﹤0.01% 712
2025
Q4 		$289K Sell
1,150
-55
-5% -$14.6K ﹤0.01% 734
2025
Q3 		$346K Sell
1,205
-35
-3% -$9.38K ﹤0.01% 653
2025
Q2 		$326K Buy
1,240
+96
+8% +$23.4K ﹤0.01% 658
2025
Q1 		$266K Buy
1,144
+11
+1% +$2.67K ﹤0.01% 669
2024
Q4 		$260K Buy
1,133
+21
+2% +$4.82K ﹤0.01% 657
2024
Q3 		$249K Buy
+1,112
New +$244K ﹤0.01% 659

Other funds holding LH

RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
DIA
Davidson Investment Advisors Great Falls, Montana $2.45B AUM 21.8% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
HPCM
Hunter Perkins Capital Management Lombard, Illinois $446M AUM 25.88% 1-Year Est. Return
MCM
McRae Capital Management Morristown, New Jersey $508M AUM 14.21% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

Ballentine Partners's LH Position: Q2 2026 in Review

Ballentine Partners reduced its Labcorp (LH) stake by 2.4% in Q2 2026, selling an estimated $7.62K and leaving 1,160 shares worth $325K. The position accounts for ﹤0.01% of the portfolio, ranked #752.

Ballentine Partners first reported a position in LH in Q3 2024 and has held it in 8 quarters since. The position peaked at $346K in Q3 2025. 201 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Ballentine Partners held 1,160 shares of Labcorp worth $325K as of Q2 2026.
  • Ballentine Partners sold 29 Labcorp shares in Q2 2026, an estimated $7.62K.
  • Labcorp made up ﹤0.01% of Ballentine Partners's portfolio in Q2 2026, its #752 holding.
  • Ballentine Partners first reported a position in Labcorp in Q3 2024 and has held it in 8 quarters since.
  • Ballentine Partners's Labcorp position peaked at $346K in Q3 2025.
  • 201 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.